← Eichor
Condition: Healthy Volunteer Study Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Healthy Volunteer Study

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
Phase 1 · 2 location(s) · HTIC, Inc · NCT07449572A Food-Effect Study of CX11 in Healthy Participants
Phase 1 · 1 location(s) · Vincentage Pharma Co., Ltd · NCT07349381The ENHANCE Study: taVNS and Psilocybin
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT05866471Ayahuasca, Esketamine and Premenstrual Symptoms
NA · 1 location(s) · University of Sao Paulo · NCT07317232Montbretin Clinical Trial in Healthy Volunteers and Type 2 Diabetics
Phase 1 · 1 location(s) · Robert Petrella · NCT05826054Inhaled RB042 in Healthy Adult Volunteers and Healthy Adult Smokers
Phase 1 · 1 location(s) · Atisama Therapeutics · NCT07285122A Clinical Study of AK0610
Phase 1 · 1 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06996704Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.
Phase 1 · 3 location(s) · HC Biopharma Inc. · NCT06657703A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Parti
Phase 2 · 8 location(s) · ModernaTX, Inc. · NCT07561294Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications
Phase N/A · 1 location(s) · Tethis S.p.A. · NCT05942066Microneurography and Intraneural Microstimulation for Upper Limb Sensory Investigation in Healthy and Amputee Subjects
NA · 1 location(s) · Azienda Ospedaliero, Universitaria Pisana · NCT07691957A Study of Psychedelics in Healthy Older Adults With Low Well-being
Phase 1 · 1 location(s) · Jennifer Mitchell · NCT07386730A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled R
Phase 1 · 1 location(s) · Revagenix, Inc. · NCT07709494A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
Phase 1 · 1 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT06839131Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT07058779A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administratio
Phase 1 · 3 location(s) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07204418Phase 1 Single Ascending Dose Study
Phase 1 · 1 location(s) · Neuramedy Co. Ltd. · NCT06934941Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers
EARLY_Phase 1 · 2 location(s) · National Institute of Mental Health (NIMH) · NCT06484088A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participant
Phase 1/Phase 2 · 1 location(s) · MindRank AI Ltd · NCT06778850A Study of YP05002 in Healthy Participants
Phase 1 · 1 location(s) · Yaopharma Co., Ltd. · NCT07089823Antibiotics and Vaccine Immune Responses Study
Phase 4 · 1 location(s) · South Australian Health and Medical Research Institute · NCT06148025A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
Phase 1 · 1 location(s) · Hoffmann-La Roche · NCT07495813A Study of V118E in Healthy Participants (V118E-003)
Phase 1 · 4 location(s) · Merck Sharp & Dohme LLC · NCT07168915Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
Phase 1 · 1 location(s) · Prestige Biopharma Limited · NCT05108259Multi-omics Database Construction of Healthy Korean Volunteers
Phase N/A · 1 location(s) · Kyunghee University Medical Center · NCT06183697FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Phase 1 · 5 location(s) · Pfizer · NCT06564389Study to Evaluate the Pharmacokinetics (PK) of E7090 (Herein Referred to as Tasurgratinib) and Its Metabolite in Partici
Phase 1 · 8 location(s) · Eisai Co., Ltd. · NCT04271488A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061
Phase 1 · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07241910Phase 1 Study of Intravaginal KB15A
Phase 1 · 1 location(s) · ZabBio Inc. · NCT07222020
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.